Relation of protein oxidation parameters and disease activity in patients with Behçet's disease

Behçet's disease (BD) is a chronic inflammatory vasculitis characterized by endothelial dysfunction, elevated reactive oxygen species (ROS), and neutrophil hyperfunction production including acute attacks and remission periods. Ischemia modified albumin (IMA), advanced oxidation protein product...

Full description

Saved in:
Bibliographic Details
Published in:Clinical laboratory (Heidelberg) Vol. 59; no. 7-8; p. 819
Main Authors: Ozyazgan, S, Andican, G, Erman, H, Tuzcu, A, Uzun, H, Onal, B, Ozyazgan, Y
Format: Journal Article
Language:English
Published: Germany 2013
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Behçet's disease (BD) is a chronic inflammatory vasculitis characterized by endothelial dysfunction, elevated reactive oxygen species (ROS), and neutrophil hyperfunction production including acute attacks and remission periods. Ischemia modified albumin (IMA), advanced oxidation protein products (AOPP), prooxidants-antioxidants balance (PAB), and ferric reducing antioxidant power (FRAP) were evaluated in regard to their role in the pathogenesis of BD as well as their relation to clinical presentation, uveitis attacks and remission periods, and healthy volunteers. The study included 28 BD cases and 27 healthy volunteers as the control group. Blood samples were taken twice from each patient; first during an attack and second about three months after an attack, during remission period. AOPP, IMA and PAB levels were significantly increased in active periods of patients with BD compared with healthy control and remission periods of patients with BD (p < 0.0001, p < 0.0001, p < 0.0001, respectively). FRABP levels were found to be lower in active periods of patients with than healthy controls and remission periods of patients with BD (p < 0.001, p < 0.05, respectively). The AOPP levels were negatively correlated with the levels of FRAB in patients (r = -0.468, p = 0.012; r = -0.394, p = 0.038, respectively). The PAB levels were positively correlated with the levels of CRP in patients (r = -0.606, p = 0.001). Our results show that these parameters play a major role in the inflammatory reactions observed in BD. Increased levels of IMA and PAB are likely to be a result of inflammation-induced oxidative stress and hence its potential significance as a new marker of oxidative stress in BD.
AbstractList Behçet's disease (BD) is a chronic inflammatory vasculitis characterized by endothelial dysfunction, elevated reactive oxygen species (ROS), and neutrophil hyperfunction production including acute attacks and remission periods. Ischemia modified albumin (IMA), advanced oxidation protein products (AOPP), prooxidants-antioxidants balance (PAB), and ferric reducing antioxidant power (FRAP) were evaluated in regard to their role in the pathogenesis of BD as well as their relation to clinical presentation, uveitis attacks and remission periods, and healthy volunteers. The study included 28 BD cases and 27 healthy volunteers as the control group. Blood samples were taken twice from each patient; first during an attack and second about three months after an attack, during remission period. AOPP, IMA and PAB levels were significantly increased in active periods of patients with BD compared with healthy control and remission periods of patients with BD (p < 0.0001, p < 0.0001, p < 0.0001, respectively). FRABP levels were found to be lower in active periods of patients with than healthy controls and remission periods of patients with BD (p < 0.001, p < 0.05, respectively). The AOPP levels were negatively correlated with the levels of FRAB in patients (r = -0.468, p = 0.012; r = -0.394, p = 0.038, respectively). The PAB levels were positively correlated with the levels of CRP in patients (r = -0.606, p = 0.001). Our results show that these parameters play a major role in the inflammatory reactions observed in BD. Increased levels of IMA and PAB are likely to be a result of inflammation-induced oxidative stress and hence its potential significance as a new marker of oxidative stress in BD.
Author Ozyazgan, S
Tuzcu, A
Uzun, H
Erman, H
Ozyazgan, Y
Onal, B
Andican, G
Author_xml – sequence: 1
  givenname: S
  surname: Ozyazgan
  fullname: Ozyazgan, S
  organization: Department of Medical Pharmacology and Clinical Pharmacology, Cerrahpaşa Faculty of Medicine, Istanbul University, Istanbul, Turkey
– sequence: 2
  givenname: G
  surname: Andican
  fullname: Andican, G
– sequence: 3
  givenname: H
  surname: Erman
  fullname: Erman, H
– sequence: 4
  givenname: A
  surname: Tuzcu
  fullname: Tuzcu, A
– sequence: 5
  givenname: H
  surname: Uzun
  fullname: Uzun, H
– sequence: 6
  givenname: B
  surname: Onal
  fullname: Onal, B
– sequence: 7
  givenname: Y
  surname: Ozyazgan
  fullname: Ozyazgan, Y
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24133911$$D View this record in MEDLINE/PubMed
BookMark eNo1j81OwzAQhH0ooqX0DRDyjVOCd-3U6REq_qRKSAjOZV1vVKM2iWLz0yfiQXgxgkpPMxp9Gs2ciEHd1CzEGajc2sJczjehzhfkclSAOaCyiAMxAqN1Ni1ADcUkxjelFKhCF4DHYogGtJ4BjMTrE28ohaaWTSXbrkkcevsV_D5sqaMtJ-6ipNpLHyJTZEmrFD5C2snwh6TAdYryM6S1vOb1zzeni3hgT8VRRZvIk38di5fbm-f5fbZ4vHuYXy2ylVY2ZWzAVh6VITstHJXO27L0qvJKV-iKKRi2paWZcWRLQtuPh964yrN1rkQci_N9b_vutuyXbRe21O2Wh6v4C24gWkI
CitedBy_id crossref_primary_10_3389_fimmu_2019_02877
crossref_primary_10_1111_cei_13664
crossref_primary_10_24938_kutfd_124897
crossref_primary_10_1111_ceo_13155
crossref_primary_10_4103_err_err_66_18
crossref_primary_10_1515_tjb_2016_0296
crossref_primary_10_33204_mucosa_541578
crossref_primary_10_3389_fimmu_2019_01085
crossref_primary_10_5021_ad_2015_27_2_178
crossref_primary_10_3390_medicina58050669
crossref_primary_10_4274_raed_galenos_2022_36844
crossref_primary_10_1161_CIRCULATIONAHA_115_017738
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.7754/Clin.Lab.2012.120722
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
ExternalDocumentID 24133911
Genre Journal Article
GroupedDBID ---
29B
53G
5GY
AENEX
ALMA_UNASSIGNED_HOLDINGS
CGR
CUY
CVF
ECM
EIF
EMOBN
F5P
NPM
P2P
SJN
ID FETCH-LOGICAL-c307t-e417fd204a765ba8bd788d0fd03f2b5614e787a94ba78a27911178abfde7bb822
ISSN 1433-6510
IngestDate Thu May 23 23:19:16 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 7-8
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c307t-e417fd204a765ba8bd788d0fd03f2b5614e787a94ba78a27911178abfde7bb822
PMID 24133911
ParticipantIDs pubmed_primary_24133911
PublicationCentury 2000
PublicationDate 2013-00-00
PublicationDateYYYYMMDD 2013-01-01
PublicationDate_xml – year: 2013
  text: 2013-00-00
PublicationDecade 2010
PublicationPlace Germany
PublicationPlace_xml – name: Germany
PublicationTitle Clinical laboratory (Heidelberg)
PublicationTitleAlternate Clin Lab
PublicationYear 2013
SSID ssj0001053512
Score 2.108424
Snippet Behçet's disease (BD) is a chronic inflammatory vasculitis characterized by endothelial dysfunction, elevated reactive oxygen species (ROS), and neutrophil...
SourceID pubmed
SourceType Index Database
StartPage 819
SubjectTerms Behcet Syndrome - metabolism
Behcet Syndrome - physiopathology
Case-Control Studies
Cross-Sectional Studies
Humans
Oxidation-Reduction
Prospective Studies
Remission Induction
Title Relation of protein oxidation parameters and disease activity in patients with Behçet's disease
URI https://www.ncbi.nlm.nih.gov/pubmed/24133911
Volume 59
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV07T8MwELZaWFgQiPdLHpAYkKEkbu2OUIoYgIUisRU7tqEDBVEqQf8QP4Q_xl1sJ6UCBANLZNlRFOe-nO9hf0fItuT1xCRaswyWa8ZN2mBNkykmFNiv1mjhfOjiUlxcy-M2b1cqsa5B2fevkoY-kDWenP2DtIuHQge0QeZwBanD9Vdyj7vb8q3MSMLQg-ZLz5dO2kWm73vcAeOpmUN6JmfUyItIlEyr4djbkb3Lc-kCkxZi8CmhEwkO4uHKACjM2oPdWjJojcdyR69qdDsRdD3sY7Io7ysqfbWfQmi2SGV1hqNsWEZfQ6QCq0YUkQqvXHmaskY9bGMN2jfwgXuUCSbHlKn0ynRSySNnH5IHw-T2zpTG7XnJ3kFSE_6A85iMH-9zIWPqMG16nf7z6AT1dhyqkioYUmhrt87LAB4y4_hsepyXP5qJ77f_1dsh8XR44oQTkxsznTkyG7wQeujhM08qtr9AbiJ06IOjATq0gA4toUMBOjQAgUbo0B7e4qFDEToUoPP-Zp93BvHeRXJ10u60TlkowMEyUP3PzPID4UxS40o06lpJbYSUpuZMLXWJRg5ZC_peNblWQqpE4MIJDe2MFVqD6blEpvoPfbtCqGg4ha51ljrJDXh0gtelURrWEAMuhFkly_6DdB89y0o3fqq1b0fWyUwJsw0y7eAXtpukOjDDrVxWH39CZJc
link.rule.ids 782
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Relation+of+protein+oxidation+parameters+and+disease+activity+in+patients+with+Beh%C3%A7et%27s+disease&rft.jtitle=Clinical+laboratory+%28Heidelberg%29&rft.au=Ozyazgan%2C+S&rft.au=Andican%2C+G&rft.au=Erman%2C+H&rft.au=Tuzcu%2C+A&rft.date=2013-01-01&rft.issn=1433-6510&rft.volume=59&rft.issue=7-8&rft.spage=819&rft_id=info:doi/10.7754%2FClin.Lab.2012.120722&rft_id=info%3Apmid%2F24133911&rft_id=info%3Apmid%2F24133911&rft.externalDocID=24133911
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1433-6510&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1433-6510&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1433-6510&client=summon